Remedsan: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Remedsan
Largest movements
- Receivables within one year +€30,538
up €30,538 (+52.8%), from €57,814 to €88,352
of which Other amounts receivable: +€88,352
- Cash +€14,010
up €14,010 (+700%), from €2,000 to €16,010
mainly Net result for the year (+€26,539) and Tax, wage and social debts (+€21,693)
- Tangible fixed assets +€3,278
new in 2025: €3,278
- Reserves +€24,500
up €24,500 (+61.3%), from €40,000 to €64,500
- Tax, wage and social debts +€21,693
up €21,693 (+131%), from €16,567 to €38,260
- Profit (loss) carried forward +€1,206
up €1,206 (+96.7%), from €1,247 to €2,453
- Gross operating margin -€20,847
down €20,847 (-35.4%), from €58,859 to €38,012
- Taxes -€5,674
down €5,674 (-34.5%), from €16,442 to €10,768
- Financial income +€2,394
new in 2025: €2,394
- Depreciation +€1,942
new in 2025: €1,942
- Other operating charges +€709
up €709 (+248%), from €285 to €994
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €59,814 | €107,796 | +€47,982 | +80.2% |
| Fixed assets | 21/28 | - | €3,278 | +€3,278 | |
| Tangible fixed assets | 22/27 | - | €3,278 | +€3,278 | |
| Plant, machinery and equipment | 23 | - | €3,278 | +€3,278 | |
| Current assets | 29/58 | €59,814 | €104,518 | +€44,704 | +74.7% |
| Amounts receivable within one year | 40/41 | €57,814 | €88,352 | +€30,538 | +52.8% |
| Trade receivables | 40 | €57,814 | - | -€57,814 | |
| Other amounts receivable | 41 | - | €88,352 | +€88,352 | |
| Cash at bank and in hand | 54/58 | €2,000 | €16,010 | +€14,010 | +700% |
| Deferred charges and accrued income | 490/1 | - | €156 | +€156 | |
| Total equity and liabilities | 10/49 | €59,814 | €107,796 | +€47,982 | +80.2% |
| Equity | 10/15 | €43,247 | €68,953 | +€25,706 | +59.4% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €40,000 | €64,500 | +€24,500 | +61.3% |
| Distributable reserves | 133 | €40,000 | €64,500 | +€24,500 | +61.3% |
| Profit (loss) carried forward | 14 | €1,247 | €2,453 | +€1,206 | +96.7% |
| Amounts payable | 17/49 | €16,567 | €38,843 | +€22,276 | +134% |
| Amounts payable within one year | 42/48 | €16,567 | €38,843 | +€22,276 | +134% |
| Taxes, remuneration and social security | 45 | €16,567 | €38,260 | +€21,693 | +131% |
| Taxes | 450/3 | €16,567 | €38,260 | +€21,693 | +131% |
| Other amounts payable | 47/48 | - | €583 | +€583 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,942 | +€1,942 | |
| Other operating charges | 640/8 | €285 | €994 | +€709 | +248% |
| Gross operating margin | 9900 | €58,859 | €38,012 | -€20,847 | -35.4% |
| Operating profit (loss) | 9901 | €58,574 | €35,076 | -€23,498 | -40.1% |
| Financial income | 75/76B | - | €2,394 | +€2,394 | |
| Recurring financial income | 75 | - | €2,394 | +€2,394 | |
| Financial charges | 65/66B | €52 | €163 | +€111 | +215% |
| Recurring financial charges | 65 | €52 | €163 | +€111 | +215% |
| Profit (loss) for the period before taxes | 9903 | €58,522 | €37,307 | -€21,215 | -36.3% |
| Income taxes | 67/77 | €16,442 | €10,768 | -€5,674 | -34.5% |
| Profit (loss) for the period | 9904 | €42,080 | €26,539 | -€15,541 | -36.9% |
| Profit (loss) for the period to be appropriated | 9905 | €42,080 | €26,539 | -€15,541 | -36.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.